Ocular effects that include mydriasis are characteristic of which of the following drugs?
Which route is most preferred for Endophthalmitis treatment?
Which of the following drugs should be given in a sustained-release oral dosage form?
Which of the following is an example of a prodrug?
Cycloplegics are used for the treatment of:
In ophthalmology, if a patient is allergic to aminoesters, which local anesthetic can be safely used?
Which of the following drugs is not used in treatment of iridocyclitis:
Surgery of choice for chronic acquired dacryocystitis
Which of the following drugs possesses similar cycloplegic action and is a more potent mydriatic than atropine?
Which of the following drugs is used as adjunct therapy for the treatment of fungal corneal ulcer?
Explanation: ***phenylephrine (alpha agonist)*** - **Phenylephrine** is a direct-acting **alpha-1 adrenergic agonist** that causes contraction of the **pupillary dilator muscle**, leading to **mydriasis** (pupil dilation). [1] - It is frequently used clinically to dilate pupils for **ophthalmologic examinations** due to its selective action on alpha-1 receptors in the eye. [2] *neostigmine (cholinesterase inhibitor)* - **Neostigmine** inhibits acetylcholinesterase, increasing acetylcholine at the neuromuscular junction and muscarinic receptors. This leads to **miosis** (pupil constriction), not mydriasis. - Its ophthalmic use is primarily for treating **glaucoma** by improving aqueous humor outflow through cholinergic effects on the ciliary muscle. *phentolamine (alpha blocker)* - **Phentolamine** is a **non-selective alpha-adrenergic antagonist** that blocks both alpha-1 and alpha-2 receptors. - Alpha-1 receptor blockade in the eye would relax the pupillary dilator muscle, leading to **miosis** or prevention of mydriasis, not its induction. *mecamylamine (ganglionic blocker)* - **Mecamylamine** is a **ganglionic blocker** that antagonizes nicotinic receptors in both sympathetic and parasympathetic ganglia. - Blocking parasympathetic ganglia can cause some mydriasis, but ganglionic blockers have widespread, non-selective autonomic effects and are not primarily used for isolated mydriasis.
Explanation: ***Intravitreal antibiotic*** - **Intravitreal injection** directly delivers a high concentration of antibiotics into the **vitreous cavity**, which is essential for treating intraocular infections like endophthalmitis. - This route bypasses protective barriers like the **blood-retinal barrier**, ensuring therapeutic drug levels reach the infection site promptly and effectively. *Oral antibiotic* - **Oral antibiotics** have poor penetration into the **vitreous humor** due to the **blood-retinal barrier**, making them generally ineffective as a sole therapy for endophthalmitis. - They may be used as an adjunct in some cases but cannot achieve the high local concentrations needed to resolve severe intraocular infections. *Intravenous antibiotic* - Similar to oral antibiotics, **intravenous antibiotics** struggle to penetrate the **blood-retinal barrier** adequately to achieve therapeutic concentrations in the vitreous humor for endophthalmitis. - While they can be administered in severe cases, they do not provide the direct, high-dose delivery needed to control the infection within the eye as effectively as intravitreal injections. *Topical antibiotic* - **Topical antibiotics** primarily reach the ocular surface and anterior segment of the eye, with very limited penetration into the **vitreous cavity**. - They are generally ineffective for treating endophthalmitis, which is an infection of the inner eye, and are typically reserved for superficial ocular infections.
Explanation: *An anti-arrhythmic drug with a plasma half life of 10 seconds used for acute treatment of PSVT* - An extremely short **half-life** (10 seconds) indicates a drug suitable for **rapid-onset, acute interventions**, where the effect is needed immediately and for a very brief duration, making sustained release impractical. - Drugs like **adenosine**, used for acute PSVT, are given intravenously as a rapid bolus due to their ultra-short half-life, not in an oral sustained-release form. *Anti inflammatory drugs with the plasma half life of 24 hours* - A long **half-life** (24 hours) typically means the drug can be administered **once daily** to maintain therapeutic concentrations, rendering a sustained-release formulation unnecessary. - Such drugs already provide **prolonged action** and do not benefit significantly from further extension of release. *Hypnotic drugs with a plasma half life of 2 hours* - While a 2-hour half-life for a hypnotic might suggest potential for sustained release to prolong sleep, the goal of hypnotics is often a **rapid onset and relatively short duration** to avoid hangover effects. - Sustained release might cause **daytime sedation** and interfere with normal wakefulness, which is generally undesirable for this class of drugs. ***An antihypertensive with a plasma half-life of 3 hours*** - A short **half-life** (e.g., 3 hours) often necessitates frequent dosing to maintain therapeutic levels, making a **sustained-release formulation desirable** for patient compliance and consistent drug exposure. - Sustained-release dosage forms are particularly useful for drugs requiring **long-term, stable plasma concentrations**, such as antihypertensives, to manage chronic conditions effectively.
Explanation: ***Levodopa is a prodrug that converts to dopamine.*** - A **prodrug** is an inactive precursor of a drug that is converted into its active form within the body. - **Levodopa** is converted to the active neurotransmitter **dopamine** in the brain, making it effective for Parkinson's disease. *Primidone is an anticonvulsant with active metabolites.* - While Primidone has **active metabolites** (phenobarbital and phenylethylmalonamide), the parent drug itself also possesses significant **anticonvulsant activity**, meaning it is not an inactive precursor. - A true prodrug is therapeutically inactive until metabolized. *Digitoxin is a cardiac glycoside that acts directly.* - **Digitoxin** is a cardiac glycoside that directly inhibits the **Na+/K+-ATPase pump**, exerting its therapeutic effect without requiring conversion to an active metabolite. - It does not undergo enzymatic conversion to an active form to produce its primary action. *Amitriptyline is an antidepressant that acts directly.* - **Amitriptyline** is a **tricyclic antidepressant** that directly inhibits the reuptake of norepinephrine and serotonin. - While it is metabolized to an active metabolite (nortriptyline), Amitriptyline itself is **pharmacologically active** as the parent drug.
Explanation: ***Iridocyclitis*** - **Cycloplegics** paralyze the **ciliary muscle** and **iris sphincter**, reducing spasm and pain associated with inflammation in iridocyclitis. - They also help prevent the formation of **posterior synechiae**, adhesions between the iris and the lens. - This is the **primary therapeutic indication** for cycloplegics in inflammatory conditions. *Lens-induced glaucoma* - This condition is caused by **lens swelling** or **leakage of lens material**, leading to elevated intraocular pressure. - Treatment typically involves **surgical removal of the cataractous lens**, not cycloplegics. *Closed-angle glaucoma* - Cycloplegics are **CONTRAINDICATED** in closed-angle glaucoma as they cause **pupillary dilation**, which can precipitate or worsen angle closure. - The condition is characterized by **blockage of aqueous humor outflow** due to the iris obstructing the trabecular meshwork. - Treatment involves methods to open the angle, such as **laser iridotomy** or medications that **constrict the pupil** (miotics) or reduce aqueous humor production. *Chorioretinitis* - This is an **inflammation of the choroid and retina**, layers located at the back of the eye (posterior segment). - Treatment primarily involves **systemic anti-inflammatory agents** and antimicrobials if infectious. - Cycloplegics do not directly address posterior segment inflammation, though they may be used for symptomatic relief if anterior chamber reaction is present.
Explanation: **Local anesthetics are classified into two chemical groups: esters (aminoesters) and amides. Allergies to esters typically do not cross-react with amides.** ***Prilocaine*** - **Prilocaine** is an **amide-type local anesthetic**, and allergies to **aminoesters** typically do not cross-react with **amides**. - It is a safe alternative in patients with a known allergy to **ester-type local anesthetics**. *Cocaine* - **Cocaine** is an **ester-type local anesthetic**, sharing a similar chemical structure with **aminoesters**. - Patients allergic to **aminoesters** are likely to experience a **cross-reaction** with **cocaine**. *Procaine* - **Procaine** is a classic **ester-type local anesthetic** (an aminoester). - An allergy to aminoesters directly implies an allergy to **procaine** due to its chemical classification. *Tetracaine* - **Tetracaine** is also an **ester-type local anesthetic** (an aminoester). - It is contraindicated in patients with an allergy to **aminoesters** due to the high risk of **allergic reaction**.
Explanation: ***Timolol eye drops*** - **Timolol** is a **beta-blocker** used to reduce intraocular pressure in **glaucoma** by decreasing aqueous humor production. - It has **no role in iridocyclitis management** as it does not address inflammation, pain, or pupillary abnormalities, which are the key therapeutic targets. - Timolol is simply not part of the treatment protocol for iridocyclitis. *Pilocarpine eye drops* - **Pilocarpine** is a **miotic** agent that constricts the pupil, but it is **contraindicated** in iridocyclitis (not just "not used"). - While not used therapeutically, it's important to distinguish that pilocarpine is actively harmful (increases inflammation and posterior synechiae risk), whereas timolol is simply not indicated. - In the context of this question asking what is "not used in treatment," timolol is the better answer as it's not part of the standard treatment protocol. *Atropine eye ointment* - **Atropine** is a **cycloplegic and mydriatic** agent that is a **cornerstone of iridocyclitis treatment**. - It dilates the pupil and paralyzes the ciliary muscle to prevent and break **posterior synechiae** and relieve pain from ciliary muscle spasm. - By immobilizing the iris and ciliary body, it reduces inflammation and discomfort. *Steroid eye drops* - **Steroid eye drops** (e.g., prednisolone acetate) are **essential for managing iridocyclitis** as they effectively reduce inflammation within the anterior chamber. - They suppress the immune response causing inflammation, thereby alleviating symptoms like redness, pain, and photophobia. - Topical corticosteroids are the mainstay of anti-inflammatory treatment in anterior uveitis.
Explanation: ***Dacryocystorhinostomy*** - This procedure creates a new connection between the **lacrimal sac** and the **nasal cavity**, bypassing the obstructed nasolacrimal duct. - It is the **surgery of choice** for chronic acquired dacryocystitis as it provides a permanent solution for tear drainage. *Dacryocystectomy* - This involves **excision of the lacrimal sac**, which can relieve symptoms of infection but eliminates the sac's function. - It is generally reserved for cases where dacryocystorhinostomy is contraindicated or has failed, and is **not the primary choice** for restoring tear flow. *Conjunctivo-cystorhinostomy* - This procedure creates a bypass from the **conjunctiva** directly to the **nasal cavity**, typically used when the canaliculi are also obstructed. - It is a more complex surgery indicated for **proximal lacrimal system obstruction** (e.g., canalicular block) rather than isolated nasolacrimal duct obstruction. *None of the options* - **Dacryocystorhinostomy** is the well-established and most effective surgical intervention for chronic acquired dacryocystitis. - Therefore, this option is incorrect as there is a suitable surgical choice available.
Explanation: **Explanation:** The correct answer is **Hyoscine (Scopolamine)**. **Why Hyoscine is the correct answer:** Hyoscine is a belladonna alkaloid that acts as a competitive antagonist at muscarinic receptors. In terms of ocular potency, it is significantly more potent than atropine on a weight-for-weight basis. While it produces a **similar degree of cycloplegia** (paralysis of the ciliary muscle), it is a **more potent mydriatic** (pupillary dilator) than atropine. Its duration of action (3–7 days) is shorter than that of atropine (7–10 days), making it a useful alternative when a potent but slightly shorter-acting cycloplegic is required. **Analysis of Incorrect Options:** * **Tropicamide:** This is the shortest-acting mydriatic (duration 4–6 hours). While it is excellent for fundus examination, its cycloplegic action is much weaker and shorter than atropine. * **Homatropine:** A semi-synthetic derivative that is 10 times less potent than atropine. It has a shorter duration of action (1–3 days) and is primarily used in the treatment of anterior uveitis to prevent synechiae without the prolonged blurriness of atropine. **High-Yield Clinical Pearls for NEET-PG:** * **Potency Order:** Hyoscine > Atropine > Homatropine. * **Duration of Action (Cycloplegia):** Atropine (7–10 days) > Hyoscine (3–7 days) > Homatropine (1–3 days) > Cyclopentolate (24 hours) > Tropicamide (6 hours). * **Drug of Choice:** Atropine is the drug of choice for refraction in children <5 years (due to strong accommodation), while Homatropine/Cyclopentolate is preferred for older children. * **Side Effect:** Systemic absorption of atropine in children can lead to "Atropine flushing," fever, and tachycardia.
Explanation: **Explanation:** In the management of a fungal corneal ulcer, **Atropine (1%) eye drops** serve as a vital adjunct therapy. The primary medical rationale for its use is to manage **secondary ciliary body inflammation (iridocyclitis)**, which is a common complication of deep corneal ulcers. **Why Atropine is the Correct Answer:** 1. **Ciliary Muscle Relaxation:** It acts as a cycloplegic, paralyzing the ciliary muscle to relieve the intense pain caused by ciliary spasms. 2. **Prevention of Synechiae:** As a potent mydriatic, it dilates the pupil, preventing the formation of posterior synechiae (adhesion of the iris to the lens). 3. **Reduction of Exudation:** It reduces the permeability of iris vessels, thereby decreasing the inflammatory exudate in the anterior chamber. **Why Other Options are Incorrect:** * **Dexamethasone:** Steroids are strictly **contraindicated** in active fungal ulcers as they promote fungal growth, inhibit collagen synthesis (leading to corneal perforation), and suppress the local immune response. * **Pilocarpine:** This is a miotic. It would worsen the pain by causing ciliary muscle contraction and increase the risk of pupillary block and synechiae formation. * **Lidocaine:** While a local anesthetic, it is not used as a therapeutic adjunct; chronic use is toxic to the corneal epithelium and can delay healing. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC) for Fungal Keratitis:** Natamycin (5% suspension) is the first-line topical antifungal. * **The "Steroid Rule":** Never use steroids in a dendritic (Herpetic) or fungal ulcer. * **Atropine Duration:** It is the longest-acting cycloplegic (effect lasts 7–10 days). * **Fungal Ulcer Features:** Look for "feathery margins," "satellite lesions," and a "dry/leathery" appearance in clinical vignettes.
Get full access to all questions, explanations, and performance tracking.
Start For Free